On Invalid Date, Agenus (NASDAQ: AGEN) reported Q2 2022 earnings per share (EPS) of -$0.17, up 54.05% year over year. Total Agenus earnings for the quarter were -$46.49 million. In the same quarter last year, Agenus's earnings per share (EPS) was -$0.37.
On Invalid Date, Agenus (NASDAQ: AGEN) reported Q2 2022 revenue of $20.93 million up 95.02% year over year. In the same quarter last year, Agenus's revenue was $10.73 million.
What was AGEN's revenue growth in the past year?
As of Q3 2022, Agenus's revenue has grown 366.97% year over year. This is 753.75 percentage points lower than the US Biotechnology industry revenue growth rate of 1,120.72%. Agenus's revenue in the past year totalled $320.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.